Paper36916933
The Dual Benefit of Sulfasalazine on Pneumocystis Pneumonia-Related Immunopathogenesis and Antifungal Host Defense Does Not Require IL-4Rα-Dependent Macrophage Polarization.
Zhang ZQ and 2 others. Infect Immun, 2023. Cited by 4 papers, by iCite.
Cite this record
ConductScience Library. The Dual Benefit of Sulfasalazine on Pneumocystis Pneumonia-Related Immunopathogenesis and Antifungal Host Defense Does Not Require IL-4Rα-Dependent Macrophage Polarization. Papers, record 36916933. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36916933
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The Dual Benefit of Sulfasalazine on Pneumocystis Pneumonia-Related Immunopathogenesis and Antifungal Host Defense Does Not Require IL-4Rα-Dependent Macrophage Polarization.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Pneumonia, Pneumocystis | Major topic |
| Pneumocystis | Major topic |
| Mice | |
| Animals | |
| Sulfasalazine | |
| Antifungal Agents | |
| Macrophages | |
| Macrophages, Alveolar |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 AI117288 | NIAID NIH HHS | United States | R01AI117288 | PubMed and NIH | NIH RePORTER |
| R01 AI146035 | NIAID NIH HHS | United States | R01AI146035 | PubMed and NIH | NIH RePORTER |
| R01 HL113495 | NHLBI NIH HHS | United States | R01HL113495 | PubMed and NIH | NIH RePORTER |
References60
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 12874234 | Clearance of Pneumocystis carinii in mice is dependent on B cells but not on P carinii-specific antibody. | J Immunol | 2003 | https://conductscience.org/library/papers/12874234 | PubMed |
| 2 | 9872630 | Lymphocytes in host defense against Pneumocystis carinii. | Semin Respir Infect | 1998 | https://conductscience.org/library/papers/9872630 | PubMed |
| 3 | 2049039 | Mechanisms and modulation of macrophage activation. | Behring Inst Mitt | 1991 | https://conductscience.org/library/papers/2049039 | PubMed |
| 4 | 15824083 | Intestinal antiinflammatory effect of 5-aminosalicylic acid is dependent on peroxisome proliferator-activated receptor-gamma. | J Exp Med | 2005 | https://conductscience.org/library/papers/15824083 | PubMed |
| 5 | 27855071 | High Prevalence of Pneumocystis jirovecii Dihydropteroate Synthase Gene Mutations in Patients with a First Episode of Pneumocystis Pneumonia in Santiago, Chile, and Clinical Response to Trimethoprim-Sulfamethoxazole Therapy. | Antimicrob Agents Chemother | 2017 | https://conductscience.org/library/papers/27855071 | PubMed |
| 6 | 12920251 | IL-4 receptor signaling is required for mannose receptor expression by macrophages recruited to granulomata but not resident cells in mice infected with Schistosoma mansoni. | Lab Invest | 2003 | https://conductscience.org/library/papers/12920251 | PubMed |
| 7 | 19706447 | Tolerance and M2 (alternative) macrophage polarization are related processes orchestrated by p50 nuclear factor kappaB. | Proc Natl Acad Sci U S A | 2009 | https://conductscience.org/library/papers/19706447 | PubMed |
| 8 | 10545529 | Immune-mediated inflammation directly impairs pulmonary function, contributing to the pathogenesis of Pneumocystis carinii pneumonia. | J Clin Invest | 1999 | https://conductscience.org/library/papers/10545529 | PubMed |
| 9 | 1540135 | Inhibition of folate-dependent enzymes by non-steroidal anti-inflammatory drugs. | Biochem J | 1992 | https://conductscience.org/library/papers/1540135 | PubMed |
| 10 | 32500040 | Epidemiology of Pneumocystis jirovecii Pneumonia and (Non-)use of Prophylaxis. | Front Cell Infect Microbiol | 2020 | https://conductscience.org/library/papers/32500040 | PubMed |
| 11 | 7911424 | Interleukin-13 alters the activation state of murine macrophages in vitro: comparison with interleukin-4 and interferon-gamma. | Eur J Immunol | 1994 | https://conductscience.org/library/papers/7911424 | PubMed |
| 12 | 17145890 | p50 nuclear factor-kappaB overexpression in tumor-associated macrophages inhibits M1 inflammatory responses and antitumor resistance. | Cancer Res | 2006 | https://conductscience.org/library/papers/17145890 | PubMed |
| 13 | 9143691 | Nitric oxide and macrophage function. | Annu Rev Immunol | 1997 | https://conductscience.org/library/papers/9143691 | PubMed |
| 14 | 11159965 | Pulmonary inflammation disrupts surfactant function during Pneumocystis carinii pneumonia. | Infect Immun | 2001 | https://conductscience.org/library/papers/11159965 | PubMed |
| 15 | 9802878 | Regulation of an essential innate immune response by the p50 subunit of NF-kappaB. | J Clin Invest | 1998 | https://conductscience.org/library/papers/9802878 | PubMed |
| 16 | 29652202 | Effect of sulfasalazine use on the presence of Pneumocystis organisms in the lung among patients with rheumatoid arthritis: A test-negative design case-control study with PCR tests. | Mod Rheumatol | 2019 | https://conductscience.org/library/papers/29652202 | PubMed |
| 17 | 21220696 | IL-33 and M2a alveolar macrophages promote lung defense against the atypical fungal pathogen Pneumocystis murina. | J Immunol | 2011 | https://conductscience.org/library/papers/21220696 | PubMed |
| 18 | 17681149 | PPARgamma activation primes human monocytes into alternative M2 macrophages with anti-inflammatory properties. | Cell Metab | 2007 | https://conductscience.org/library/papers/17681149 | PubMed |
| 19 | 30658203 | Novel dihydropteroate synthase gene mutation in Pneumocystis jirovecii among HIV-infected patients in India: Putative association with drug resistance and mortality. | J Glob Antimicrob Resist | 2019 | https://conductscience.org/library/papers/30658203 | PubMed |
| 20 | 1613462 | Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation. | J Exp Med | 1992 | https://conductscience.org/library/papers/1613462 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40474676 | Fungal β-glucan instructed miR-32-5p modulates Dectin-1 signaling mediated inflammation, reactive oxygen species and apoptosis through polarization of "M2a-like" macrophage in Candida colitis. | Virulence | 2025 | https://conductscience.org/library/papers/40474676 | PubMed |
| 39150267 | Protective innate immunity against Pneumocystis does not require Stat6-dependent macrophage polarization. | Infect Immun | 2024 | https://conductscience.org/library/papers/39150267 | PubMed |
| 37721419 | IFN-γ Limits Immunopathogenesis but Delays Fungal Clearance during Pneumocystis Pneumonia. | J Immunol | 2023 | https://conductscience.org/library/papers/37721419 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36916933
GET https://conductscience.org/api/papers/v1/36916933/references?page=2